東生華

+0.15 (+0.30%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

50.0023成交張數11.49本益比1.36股價淨值比5.22%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	20	14	17.2%	4.33	36.85	12.1%	8.6%	0.4	0.4
2026Q1	20	15	11.6%	6.44	38.42	10.3%	7.6%	1.7	1.7
2025Q4	20	14	12.0%	6.27	37.57	9.8%	7.3%	0.4	0.4
2025Q3	20	14	15.7%	4.77	37.55	8.8%	6.4%	0.3	0.3
2025Q2	19	13	14.8%	4.94	34.93	8.7%	6.4%	0.4	0.4
2025Q1	19	14	12.6%	5.86	36.57	7.6%	6.0%	0.3	0.3
2024Q4	18	14	11.9%	6.25	36.25	9.0%	7.0%	0.8	0.8
2024Q3	19	14	14.4%	5.10	36.53	9.6%	7.8%	0.4	0.4
2024Q2	17	13	12.9%	5.39	34.03	7.4%	6.0%	0.2	0.2
2024Q1	15	13	7.5%	10.89	33.25	7.8%	6.8%	0.5	0.5
2023Q4	14	11	9.6%	8.33	28.85	5.7%	4.9%	0.2	0.2
2023Q3	12	11	6.3%	12.57	28.13	5.0%	4.7%	-0.1	-0.1
2023Q2	12	11	12.1%	6.62	27.86	5.2%	4.6%	0.4	0.4
2023Q1	12	11	6.3%	13.10	28.34	4.9%	4.6%	-0.1	-0.1
2022Q4	12	11	7.5%	11.00	27.80	5.8%	5.3%	0.2	0.2
2022Q3	11	11	5.6%	13.98	27.67	6.3%	5.8%	0.2	0.2
2022Q2	12	11	10.6%	7.43	27.44	5.6%	5.0%	0.4	0.3
2022Q1	12	11	5.9%	13.36	28.53	5.1%	4.7%	-0.0	-0.0
2021Q4	12	11	7.3%	10.72	28.22	4.3%	3.9%	0.1	0.1
2021Q3	13	11	13.0%	6.04	28.44	4.3%	3.8%	0.2	0.2
2021Q2	12	11	12.7%	6.17	28.41	4.8%	4.2%	0.2	0.2
2021Q1	12	11	8.0%	9.98	29.61	4.3%	4.0%	0.2	0.2
2020Q4	12	11	8.4%	9.57	29.33	5.5%	4.9%	0.1	0.0
2020Q3	12	11	8.3%	8.89	28.83	4.7%	4.3%	0.2	0.1
2020Q2	13	11	13.1%	5.52	28.72	7.6%	6.6%	0.2	0.2
2020Q1	12	11	8.8%	8.31	27.44	7.5%	6.9%	-0.3	-0.3
2019Q4	13	11	11.0%	6.38	29.30	7.6%	6.9%	0.1	0.0
2019Q3	12	11	9.7%	7.02	29.15	7.9%	7.2%	0.5	0.5
2019Q2	13	11	13.2%	5.36	28.50	4.7%	4.0%	0.2	0.2
2019Q1	13	12	8.1%	8.76	30.57	4.1%	3.8%	0.1	0.1
2018Q4	12	11	8.2%	9.01	29.19	5.1%	4.6%	0.1	0.1
2018Q3	12	11	7.7%	9.84	29.50	5.5%	5.1%	0.0	0.0
2018Q2	14	11	16.3%	4.78	29.52	6.1%	5.1%	0.1	0.1
2018Q1	13	12	7.6%	9.96	32.28	6.4%	5.9%	0.4	0.4
2017Q4	13	11	10.5%	7.38	29.86	5.0%	4.6%	0.0	0.0
2017Q3	13	12	8.2%	9.29	30.67	4.7%	4.3%	0.3	0.3
2017Q2	15	13	14.9%	4.90	32.56	3.3%	2.8%	0.4	0.4
2017Q1	15	14	6.5%	10.47	37.61	7.1%	6.6%	0.1	0.1
2016Q4	16	15	7.5%	9.01	37.77	–	–	-0.0	-0.0
2016Q3	14	13	8.3%	9.04	33.29	–	–	-0.0	-0.0